Watch on Radcliffe Vascular: [ Ссылка ]
Dr Koen Deloose (AZSint Blasius Hospital Dendermonde, BE) sits down to discuss the findings of the PRIZER Study in a cohort of 90 patients with superficial femoral artery disease.
The PRIZER Study set out to confirm the safety and efficacy of the Renzan™ stent system in the treatment of superficial femoral and popliteal artery disease. In this interview, Dr Deloose focuses on the endovascular outcomes of the SFA Patients within this cohort.
Recorded remotely from Dendermonde, 2022.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
